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Abstract To know whether the protein released from chaper- 
onin GroEL/ES is in a form committed to the native state or still 
an aggregatable non-native one, two experiments were carried 
out. Dilution of the [GroEL-substrate protein] binary complex 
prior to ATP addition significantly improved the yield of folding, 
suggesting that the released protein has a tendency to aggregate. 
When N-ethylmaleimide treated GroEL, which can form the bi- 
nary complex but not release the bound protein, was added to the 
binary complex prior to ATP addition, productive folding was 
severely inhibited, indicating that the protein released from 
GroEL/ES can bind to N-ethylmaleimide treated chaperonin. 
These data favor the 'reservoir' or 'reversion' model, in which 
GroELIES acts as a buffer of folding intermediate or mediates 
reversion of a misfolded protein to a less folded primitive form, 
rather than the 'marsupium' model in which folding of the sub- 
strate protein proceeds in chaperonin. 
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I. Introduction 
The Escherichia coli heat shock protein GroEL and its ho- 
mologs in other organisms belong to a chaperonin (or hsp60) 
family of molecular chaperones [1-4]. They are well conserved 
in amino acid sequences, ubiquitous, and indispensable for 
living cells [1,5,6]. GroEL is composed of two stacked heptamer 
rings of 60 kDa subunits [7 9], and its crystal structure has been 
determined recently by Braig et al. [10]. Isolated 60 kDa subunit 
has primitive chaperone activity [11,12]. GroEL captures labile 
folding intermediate o form binary complex and, with aid of 
ATP and the co-chaperonin (E. coli GroES), the intermediate 
is slowly released from GroEL/ES to continue productive fold- 
ing [13-15]. 
There seems to be a general agreement that the major role 
of chaperonin to assist protein folding is prevention of aggre- 
gate formation of unfolded or partially folded proteins [16]. We 
discussed two possible models to explain how chaperonin can 
do so [17]. One model, which we call 'marsupium' (kangaroo's 
bag) model (Fig. la), assumes that the central cavity provides 
a closed microcompartment in which protein folding proceeds 
without risk of aggregation until the protein takes a structure 
which no longer have tendency to aggregate. According to this 
model, the released protein (I~) can not rebind to chaperonin. 
In the marsupium odel the role of chaperonin appears to be 
a folding catalyst. On the contrary, in the second model, which 
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we call the 'reservoir' model, the role of chaperonin is simple, 
just to keep folding intermediate (I0 concentration in the solu- 
tion low by rapid binding and ATP-regulated slow release (Fig. 
lb). Since aggregation is highly dependent on folding interme- 
diate concentration, this can be enough to suppress aggregation 
(see computer simulations [17,18]). Recently, the third model 
('reversion' model) was postulated by Todd et al. (Fig. lc) [19]. 
It assumes that chaperonin binds misfolded form (I2) of sub- 
strate protein, which tends to aggregate, reverts the form to a 
less folded one (I0, and releases it to resume partitioning be- 
tween native and misfolded forms. Key differences between the 
marsupium odel and other two models exist in whether or not 
the form of protein released from chaperonin (or other form 
derived from the released form) has tendency to aggregate and 
whether or not it can rebind to chaperonin. 
The explanation ofchaperonin function based on the marsu- 
pium model has been widely accepted since it can explain func- 
tional meaning of a central cavity of chaperonin [20-22]. How- 
ever, several results that favor the reversion model were 
published recently [19,23]. Here, starting the folding reaction 
from the binary complex between chaperonin and folding inter- 
mediate of rhodanese, we have observed significant improve- 
ment of folding yield by dilution of the binary complex concen- 
tration prior to the addition of MgATR and rebinding of pro- 
teins released from the binary complex to another chaperonin. 
These results are readily explained by the reservoir and rever- 
sion models but not by the marsupium odel. 
2. Materials and methods 
2.1. Proteins 
Bovine mitochondrial rhodanese (thiosulfate sulfurtransferase, 33 
kDa monomer enzyme) type II and bovine serum albumin were pur- 
chased from Sigma. GroEL and GroES were purified as described 
previously from lysates of E. coli cells bearing the multicopy plasmid 
pACYC 184 carrying roES-groEL genes which was a kind gift from 
Dr. K. Ito [11]. Purified GroEL and GroES were stored as 65% ammo- 
nium sulfate precipitation at 4°C. Protein concentration was deter- 
mined by the method of Bradford with bovine serum albumin as a 
standard [24]. Modification of the cysteine residues of GroEL with 
N-ethylmaleimide (NEM) was performed according to Mendoza [25]. 
Briefly, GroEL (16 pM as monomer) was incubated with 5 mM NEM 
in 25 mM Tris-HCl (pH 8) for 1 h at room temperature. The reaction 
with NEM was stopped by adding 2-mercaptoethanol. This modified 
GroEL was used after emoval of excess NEM and 2-mercaptoethanol. 
2.2. GroE-assisted rhodanese folding 
Rhodanese was denatured in25 mM Tris-HC1 buffer, pH7.5, 5 mM 
dithiothreitol, 6 M guanidine HC1 at room temperature for at least 30 
min. The folding experiment consisted of four steps. The first step was 
formation of binary complex between GroEL and non-native state of 
rhodanese: denatured rhodanese was diluted (1.5/IM, final concentra- 
tion) into the dilution buffer preincubated at 37°C containing 25 mM 
Tris-HC1, pH 7.5, 5 mM dithiothreitol, 50 mM Na2S203, 40 mM KCI, 
GroEL (1.45/~M as tetradecamer) and GroES (1.7/LM as heptamer). 
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The second step was addition of several components or dilution by 
adding the buffer: details for individual experiments are given in the 
legends to figures. The third step was to permit folding: MgATP was 
supplemented to the solution. The fourth step was assay of recovered 
rhodanese activity: at the indicated time after the MgATP addition, 
aliquot was withdrawn and rhodanese activity was determined accord- 
ing to S6rbo [26]. 
3. Results 
3.1. Effect of  concentration of  binary complex on the Jolding 
yield 
According to the reservoir model, when the folding assay is 
started from the binary complex ([cpn-Ij  in Fig. lb) by the 
addition of MgATE the yield of folding should be improved 
as the concentration of the binary complex is diluted because 
the concentration f folding intermediate (I 1 in Fig. 1 b) depends 
on that of the binary complex and aggregation is greatly sup- 
pressed at low concentration of I1. The same is true for the 
reversion model (Fig. lc). To test the effect of concentration of
the binary complex on the folding yield, we chose a monomeric 
enzyme, bovine rhodanese, as a substrate protein to avoid com- 
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Fig. 1. Three possible models of chaperonin function. (a) Marsupium 
model. (b) Reservoir model. (c) Reversion model. 'U', 'I', 'N' and 'A' 
represent a completely unfolded protein, a folding intermediate, a pro- 
tein with native structure, and aggregated proteins, respectively. 'cpn' 
indicates functional chaperonin and 'cpn:I' is a complex between 
chaperonin and a folding intermediate. Note that a key difference 
between marsupium odel and the other two models exists in whether 
or not the form of protein released from chaperonin 02 of marsupium, 
I z of reservoir model) and the form derived from the released form 
02 of reversion model) has tendency to aggregate. Steps connected with 
a unidirectional rrow indicate irreversible steps. 
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Fig. 2. Effect of concentration f the [GroEL rhodanese] complex on 
the folding yield of rhodanese. Denatured rhodanese was diluted 25- 
fold to 1.5/2M at 37°C by injecting into the buffer containing 1.45/2M 
GroEL (as a 14-mer) and 1.7¢tM GroES (as a 7-mer). After incubation 
for 5 rain, a half of the solution was further diluted 4-fold by adding 
the chaperonin-depleted buffer and incubation was continued for 3 min. 
Then, MgATP (1 raM, final concentration) was added to the mixture. 
At indicated times, an aliquot was withdrawn and the recovered 
rhodanese activity was determined. Activities are shown as fractions of 
the calculated 100% activities for each concentration of native 
rhodanese. 
dependent [27,28]. Under the conditions adopted here (a final 
concentration of rhodanese concentration, 1.5 pM, at 37°C), 
denatured rhodanese cannot fold spontaneously from dena- 
tured state and forms aggregate [12,27,28]. A [GroEL- 
rhodanese] binary complex was formed by diluting the dena- 
tured rhodanese into the buffer containing GroEL, at a 
rhodanese: GroEL tetradecamer molar ratio of 1.2: 1. Small 
excess of denatured rhodanese not captured by GroEL should 
aggregate under the condition. Once non-native rhodanese is
captured by GroEL, the binary complex is stable [29] and sup- 
plement of MgATP triggers the release of bound rhodanese, 
resuming the folding of rhodanese (Fig. 2). When protein con- 
centration of the binary complex was four-fold diluted prior to 
the addition of MgATE the yield of folding was remarkably 
improved, from 44% to 90%. Since the fate of the released 
proteins is either productive folding or aggregate formation 
[28,30], the increase of productive folding should be a conse- 
quence of suppression of aggregate formation caused from 
lowering the concentration of the released proteins. Thus, im- 
provement of the folding yield by prior dilution of the binary 
complex is reasonably explained by the reservoir model in 
which proteins released from the binary complex still have 
tendency to aggregate. 
3.2. Rebinding of released protein to NEM-treated GroEL 
To test whether proteins released from the binary complex 
are capable of rebinding to another chaperonin molecule, we 
used a NEM-treated GroEL. It has been reported that GroEL 
treated with NEM is able to bind non-native rhodanese but can 
not release them even in the presence of both ATP and GroES 
[25]. In fact, NEM-treated GroEL could not mediate folding 
of rhodanese from the denatured state (Fig. 3, third column) 
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Fig. 3. Inhibition of GroE-dependent folding by NEM-treated GroEL. 
Denatured rhodanese was diluted 25-fold to 1.5 ¢tM at 37°C by inject- 
ing into the buffer containing 0¢tM (column 1), 1.45/IM (column 2, 
4, 5) GroEL or 1.45 ¢tM NEM-treated GroEL (column 3). All buffers 
also contained 1.7 ¢tM GroES. The mixtures were incubated for 5 min 
and 10 ¢tl of the dilution buffer containing following components was 
added to 25/11 of each of mixtures; buffer only (columns 1 3); GroEL 
(1.73/~M, final concentration, column 4); NEM-treated GroEL (1.73 
,uM, final concentration, column 5). After further incubation for 5 min, 
MgATP (2 mM, final concentration) was added to the mixture. At 
60 min after the addition of ATP, an aliquot of the mixture was with- 
drawn and the recovered rhodanese activity was measured. An activity 
of the same amount of native rhodanese was taken as 100%. 
under the condition where intact GroEL could (Fig. 3, second 
column). When the 2 molar excess of the NEM-treated GroEL 
(compared to native GroEL in the binary complex) was added 
into the solution containing preformed [GroEL-rhodanese] bi-
nary complex, folding of rhodanese was inhibited significantly 
(Fig. 3, fifth column). This means that the non-native 
rhodanese r leased from the binary complex is still recognizable 
by the NEM-treated GroEL. On the other hand, when the 
intact GroEL was added instead of NEM-treated GroEL to the 
binary complex, the inhibitory effect on the folding was very 
small (Fig. 3, forth column). This result is reasonable since the 
released non-native rhodanese can rebind to added intact 
GroEL, of course, but it can release again in the presence of 
MgATE 
4. Discussion 
Our previous experiment using mainly the monomeric form 
of chaperonin showed that, when folding reaction is started 
from a binary complex between chaperonin and the substrate 
protein by addition of ATP, productive folding is significantly 
inhibited by prior addition of free chaperonin orthe chaperonin 
60 monomer [12]. We took this result, together with the fact 
that excess amount of chaperonin s inhibitory for protein fold- 
ing [31 34], as an implication of the reservoir-like function of 
chaperonin [17]. The two characteristics of the protein released 
from the binary complex, tendency of aggregation and capabil- 
ity of rebinding to chaperonin, are easily explained according 
to the reservoir model and reversion model but are difficult, if 
not impossible, to explain by the marsupium odel. 
Recently, by using several mutants of GroEL that are capa- 
ble of binding non-native proteins but not releasing them even 
in the presence of both ATP and GroES, it has been demon- 
strated that GroEL-mediated protein folding proceeds by mul- 
tiple rounds of binding- release of non-native forms [23,35]. 
Similar conclusion was drawn from experiments using native 
GroEL [19,23]. Furthermore it has been reported that a eukar- 
yotic cytoplasmic chaperonin, TCP-1, releases the target pro- 
tein in a non-native form [36]. All these results are consistent 
with the reservoir and reversion models and discrimination 
between the two models should be the next problem to solve 
[19]. 
It should be appropriate to note a contradictory report on 
folding of the glutamine synthetase (GS) [37]. In the report, the 
[GS-GroEL] binary complex was concentrated before addition 
of MgATP but the yield of productive folding was not changed. 
The difference from our result may be explained by the assump- 
tion that the conditions for folding are different in the two 
proteins; 'permissive' condition for GS, while 'non-permissive' 
condition for rhodanese [38]. Under the permissive condition, 
where spontaneous folding could occur with aggregate forma- 
tion being suppressed, the effect of concentration f released 
proteins is less obvious than that under non-permissive condi- 
tion. Another possibility to explain the difference may be a 
difference in the subunit composition; rhodanese is a monomer 
protein, whereas GS is a dodecamer protein. As protein con- 
centration i creases, the yield of subunit assembly is increased 
which, in turn, can compensate he decrease of folding yield. 
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